Incyte cuts early-stage cancer drug to focus on next-gen programs
Incyte cuts early-stage cancer drug to focus on next-gen programs. Reported by BioSpace on 2026-07-29.
Incyte
Incyte is a oncology / inflammation company. See today's news for the latest developments.
Company Info
Sector:Oncology / Inflammation
Headquarters:Wilmington, Delaware, USA
Founded:1991
Website:www.incyte.com/
Upcoming Milestones & Key Dates
2026-07-28
Milestone
Initial profile created
Clinical Development Pipeline
See pipeline
Target: See pipelineRecent News
Incyte ditches phase 1-stage JAK inhibitor for next-gen options
Incyte ditches phase 1-stage JAK inhibitor for next-gen options.
Incyte lifts annual revenue forecast after settlement with CMS
Incyte lifts annual revenue forecast after settlement with CMS.
Leadership Team
See company website
Leadership team